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Supporting research 
leadership in Africa 
I read your Editorial published in 
The Lancet Global Health (May, 
2016)1 and The Lancet Diabetes and 
Endocrinology2 with some surprise. 
It is unfortunate that you neglected 
to mention that the Wellcome Trust 
has recently greatly increased its 
commitment to building research 
capacity in Africa.
In 2014, we reviewed our funding 
in Africa with the intention of 
expanding our support. Since then 
we have launched DELTAS Africa, in 
partnership with the UK’s Department 
for International Development (DFID).3 
DELTAS Africa is a £60 million scheme 
over 5 years through which we will fund 
11 consortia and expect to train up to 
2000 African researchers.4 This activity 
is in addition to our major programmes 
in Kenya, Malawi, and South Africa, the 
Human Hereditary and Health (H3A 
Africa) programme, and Global Health 
Trials, which together total more than 
£230 million of current investment. 
At the same time, with our partners 
at the UK Department for International 
Development and the Bill & Melinda 
Gates Foundation, we are establishing 
and investing in the Alliance for 
Accelerating Excellence in Science in 
Africa (AESA), the ﬁ rst and only pan-
African funding platform whose sole 
aim is to strengthen research capacity. 
With the establishment of AESA, 
we signal a real shift in the centre of 
gravity of leadership and eventually 
funding of African science to Africa.
Competition from excellent 
programmes led by African researchers 
continues to grow, and while inevitably 
this means that some will not be 
successfully funded, it is a sure sign of a 
ﬂ ourishing research environment.
I am the Head of International Operations and 
Partnerships at Wellcome Trust. I declare no other 
competing interests.
Copyright © Kay. Open Access article distributed 
under the terms of CC BY.
Simon Kay
s.kay@wellcome.ac.uk
International Operations and Partnerships, 
Wellcome Trust, London NW1 2BE, UK
1 Davies J, Mullan Z. Research capacity in 
Africa—will the sun rise again? 
Lancet Glob Health 2016; 4: e287.
2 Davies J, Mullan Z. Research capacity in 
Africa—will the sun rise again? 
Lancet Diabetes Endocrinol 2016; 4: 375.
3 The Wellcome Trust. Leading African scientists 
to drive continent’s research agenda. 
Sept 10, 2015. http://www.wellcome.ac.uk/
News/Media-oﬃ  ce/Press-releases/2015/
WTP059728.htm (accessed April 29, 2016).
4 The Wellcome Trust. Research boost creates 
more opportunities for African scientists. 
April 20, 2016. http://www.wellcome.ac.uk/ 
News/Media-oﬃ  ce/Press-releases/2016/ 
WTP060319.htm (accessed April 29, 2016).
For more on KEMRI-Wellcome 
Trust Research Programme see 
http://kemri-wellcome.org/
For more on the Malawi-
Liverpool Wellcome Trust 
Clinical Research Programme 
see http://www.mlw.medcol.mw/
For more on the Africa Centre 
For Population Health see 
http://www.africacentre.ac.za/
For more on H3A Africa see 
http://h3africa.org/
For more on the Global Health 
Trials scheme see http://www.
wellcome.ac.uk/Funding/
Biomedical-science/Funding-
schemes/Global-health-trials-
scheme/index.htm
